PTCHFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as PRTCY
PureTech Health plc
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 29, 2026
$1.48+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 7.0
- Dividend yield
- –
Share price
−$0.20 (−11.90%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
PureTech Health plc grew revenue 45.0% to $4.83M over fiscal 2024. Free cash flow was -$134.38M.
Revenue
$4.83M
+45.0% vs. a year earlier
Operating income
-$136.10M
FY2024
Free cash flow
-$134.38M
FY2024
EPS, diluted
$0.21
FY2024
Key statistics
Valuation at the latest close; fundamentals over fiscal 2024, balances at Dec 31, 2024
Valuation
- Market cap
- –
- P/E ratio
- 7.0
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $4.83M
- Net income
- $53.51M
- EPS, diluted
- $0.21
- Free cash flow
- -$134.38M
Eight years at a glance
Fiscal years 2017 to 2024, USD
Revenue
$4.83M+45.0% YoY
Operating income
-$136.10M
Net income
$53.51M
EPS, diluted
$0.21
Free cash flow
-$134.38M
Reported period